The clinical trial supply & logistics market grew from USD 26.20 billion in 2024 to USD 28.21 billion in 2025. It is expected to continue growing at a CAGR of 7.96%, reaching USD ...

Decentralized clinical trials, which allow patients to participate locally or remotely using digital tech, enroll more diverse populations than traditional trials, according to new data from the Tufts ...

Companies looking to execute decentralized clinical trials should watch out for data variability and precision as information comes in from patients’ homes or local healthcare facilities, according to ...

Over the past few years, factors like the Covid-19 pandemic have accelerated the adoption of decentralized – or Virtual - clinical trials. This approach leverages advances in digital technologies, ...

Please provide your email address to receive an email when new articles are posted on . FDA issued guidance on decentralized elements of clinical trials last fall. Investigators need to balance using ...

Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)’s PACT ...

The clinical trial supply & logistics market thrives on digital tracking, decentralized trials, and personalized medicine. Leaders are urged to adopt integrated solutions, advanced technologies, and ...

The continued maturation of decentralized clinical trials (DCTs) has given researchers the ability to securely collect real-world data on patients as they go about their daily routines. This broader ...

You're deep in clinical research operations, and decentralized clinical trials software has become the go-to for handling ...